Loading…

Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys

The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Pu...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 1996-05, Vol.93 (10), p.4957-4961
Main Authors: Keiser, Joan A., Ryan, Michael J.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3
cites
container_end_page 4961
container_issue 10
container_start_page 4957
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 93
creator Keiser, Joan A.
Ryan, Michael J.
description The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.
doi_str_mv 10.1073/pnas.93.10.4957
format article
fullrecord <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1073_pnas_93_10_4957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>38884</jstor_id><sourcerecordid>38884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3</originalsourceid><addsrcrecordid>eNqFkcGL1DAUxoMo67h6FgSleNBTZ99rkjYBLzLM7gojgug5pGnqdmyTMWndnf_elBkH14OewuP7fY987yPkOcISoaIXO6fjUtI0LJnk1QOyQJCYl0zCQ7IAKKpcsII9Jk9i3AKA5ALOyJkoGeWIC7K5toNv9k4PncnWbWvNGDPfZutd19gw6D67Cv52vMkutRl9yDqXrbyLpvNTzD7rBGvXZB-9-2738Sl51Oo-2mfH95x8vVx_WV3nm09XH1bvN7nhKMacshq05LxmZQ0WDZaWS6h53ZSG8wJTDgqAVQ3caiy4aHWNrDCNKUuU0NJz8u6wdzfVg22MdWPQvdqFbtBhr7zu1H3FdTfqm_-pqKSiSvY3R3vwPyYbRzV00di-186mWKoSgFhQ-C-InEvOKkzg67_ArZ-CSzdQBWAhaMlFgi4OkAk-xmDb04cR1FymmstUks7zXGZyvPwz54k_tpf0V0d9Nv5W7y14-09AtVPfj_ZuTOSLA7mNqeYTSoUQjP4CQGy7SA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201283658</pqid></control><display><type>article</type><title>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</title><source>PubMed Central</source><source>JSTOR</source><creator>Keiser, Joan A. ; Ryan, Michael J.</creator><creatorcontrib>Keiser, Joan A. ; Ryan, Michael J.</creatorcontrib><description>The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.93.10.4957</identifier><identifier>PMID: 8643511</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Animals ; Blood pressure ; Blood Pressure - drug effects ; Cardiovascular Agents - administration &amp; dosage ; Cardiovascular Agents - pharmacology ; Dosage ; Dose-Response Relationship, Drug ; Epidermal Growth Factor - administration &amp; dosage ; Epidermal Growth Factor - pharmacology ; Heart rate ; Heart Rate - drug effects ; Hemodynamics ; Hemodynamics - drug effects ; Hormones ; Human resources ; Humans ; Hypertension ; Infusions, Intravenous ; Macaca fascicularis ; Male ; Molecular biology ; Monkeys ; Monkeys &amp; apes ; Peptide Fragments - administration &amp; dosage ; Peptide Fragments - pharmacology ; Primates ; Rats ; Recombinant Proteins - administration &amp; dosage ; Recombinant Proteins - pharmacology ; Rodents ; Species Specificity</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1996-05, Vol.93 (10), p.4957-4961</ispartof><rights>Copyright 1996 National Academy of Sciences</rights><rights>Copyright National Academy of Sciences May 14, 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/93/10.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/38884$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/38884$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8643511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keiser, Joan A.</creatorcontrib><creatorcontrib>Ryan, Michael J.</creatorcontrib><title>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.</description><subject>Animals</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular Agents - administration &amp; dosage</subject><subject>Cardiovascular Agents - pharmacology</subject><subject>Dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Epidermal Growth Factor - administration &amp; dosage</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics</subject><subject>Hemodynamics - drug effects</subject><subject>Hormones</subject><subject>Human resources</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Infusions, Intravenous</subject><subject>Macaca fascicularis</subject><subject>Male</subject><subject>Molecular biology</subject><subject>Monkeys</subject><subject>Monkeys &amp; apes</subject><subject>Peptide Fragments - administration &amp; dosage</subject><subject>Peptide Fragments - pharmacology</subject><subject>Primates</subject><subject>Rats</subject><subject>Recombinant Proteins - administration &amp; dosage</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Rodents</subject><subject>Species Specificity</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkcGL1DAUxoMo67h6FgSleNBTZ99rkjYBLzLM7gojgug5pGnqdmyTMWndnf_elBkH14OewuP7fY987yPkOcISoaIXO6fjUtI0LJnk1QOyQJCYl0zCQ7IAKKpcsII9Jk9i3AKA5ALOyJkoGeWIC7K5toNv9k4PncnWbWvNGDPfZutd19gw6D67Cv52vMkutRl9yDqXrbyLpvNTzD7rBGvXZB-9-2738Sl51Oo-2mfH95x8vVx_WV3nm09XH1bvN7nhKMacshq05LxmZQ0WDZaWS6h53ZSG8wJTDgqAVQ3caiy4aHWNrDCNKUuU0NJz8u6wdzfVg22MdWPQvdqFbtBhr7zu1H3FdTfqm_-pqKSiSvY3R3vwPyYbRzV00di-186mWKoSgFhQ-C-InEvOKkzg67_ArZ-CSzdQBWAhaMlFgi4OkAk-xmDb04cR1FymmstUks7zXGZyvPwz54k_tpf0V0d9Nv5W7y14-09AtVPfj_ZuTOSLA7mNqeYTSoUQjP4CQGy7SA</recordid><startdate>19960514</startdate><enddate>19960514</enddate><creator>Keiser, Joan A.</creator><creator>Ryan, Michael J.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19960514</creationdate><title>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</title><author>Keiser, Joan A. ; Ryan, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular Agents - administration &amp; dosage</topic><topic>Cardiovascular Agents - pharmacology</topic><topic>Dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Epidermal Growth Factor - administration &amp; dosage</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics</topic><topic>Hemodynamics - drug effects</topic><topic>Hormones</topic><topic>Human resources</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Infusions, Intravenous</topic><topic>Macaca fascicularis</topic><topic>Male</topic><topic>Molecular biology</topic><topic>Monkeys</topic><topic>Monkeys &amp; apes</topic><topic>Peptide Fragments - administration &amp; dosage</topic><topic>Peptide Fragments - pharmacology</topic><topic>Primates</topic><topic>Rats</topic><topic>Recombinant Proteins - administration &amp; dosage</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Rodents</topic><topic>Species Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keiser, Joan A.</creatorcontrib><creatorcontrib>Ryan, Michael J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keiser, Joan A.</au><au>Ryan, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1996-05-14</date><risdate>1996</risdate><volume>93</volume><issue>10</issue><spage>4957</spage><epage>4961</epage><pages>4957-4961</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The therapeutic application of growth factors to human disease has become closer to reality with the advent of faster means of synthesizing these molecules and novel drug delivery strategies. Epidermal growth factor (EGF) belongs to a large family of molecules with the ability to modulate growth. Purified extracts of EGF have been used clinically to modulate gastrointestinal secretion of hormones and accelerate healing. EGF is also reported to have both vascular smooth muscle contractile and relaxing activity. Cardiovascular studies were performed with the bioactive 48-amino acid fragment of human EGF in rodents and primates to determine the effects of EGF on blood pressure and heart rate in conscious animals. Intravenous infusion of EGF induced an initial pressor response in rats followed by a prolonged decrease in blood pressure. In contrast, in monkeys, EGF had dose-related blood pressure-lowering effects only; significant hypotension was observed at doses ranging from 3 to 300 μ g/kg i.v. Hypotension was associated with modest tachycardia in both species. To our knowledge, this is the first report of hemodynamic effects of EGF in primates, and it clearly documents that the mitogenic role of growth factors such as EGF is but one aspect of their physiology.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>8643511</pmid><doi>10.1073/pnas.93.10.4957</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1996-05, Vol.93 (10), p.4957-4961
issn 0027-8424
1091-6490
language eng
recordid cdi_crossref_primary_10_1073_pnas_93_10_4957
source PubMed Central; JSTOR
subjects Animals
Blood pressure
Blood Pressure - drug effects
Cardiovascular Agents - administration & dosage
Cardiovascular Agents - pharmacology
Dosage
Dose-Response Relationship, Drug
Epidermal Growth Factor - administration & dosage
Epidermal Growth Factor - pharmacology
Heart rate
Heart Rate - drug effects
Hemodynamics
Hemodynamics - drug effects
Hormones
Human resources
Humans
Hypertension
Infusions, Intravenous
Macaca fascicularis
Male
Molecular biology
Monkeys
Monkeys & apes
Peptide Fragments - administration & dosage
Peptide Fragments - pharmacology
Primates
Rats
Recombinant Proteins - administration & dosage
Recombinant Proteins - pharmacology
Rodents
Species Specificity
title Hemodynamic Effects of Epidermal Growth Factor in Conscious Rats and Monkeys
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemodynamic%20Effects%20of%20Epidermal%20Growth%20Factor%20in%20Conscious%20Rats%20and%20Monkeys&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Keiser,%20Joan%20A.&rft.date=1996-05-14&rft.volume=93&rft.issue=10&rft.spage=4957&rft.epage=4961&rft.pages=4957-4961&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.93.10.4957&rft_dat=%3Cjstor_cross%3E38884%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c518t-34b0a955b46b0e1c16e590b5bd6c552195730017b05ea1258fab142cdc66190f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=201283658&rft_id=info:pmid/8643511&rft_jstor_id=38884&rfr_iscdi=true